PRECOMPETITIVE COLLABORATIONS IN PHARMACEUTICAL INDUSTRY - Collaborative Computational Technologies for Biomedical Research - page 55

4

PRECOMPETITIVE
COLLABORATIONS IN
PHARMACEUTICAL INDUSTRY

JACKIE HUNTER

4.1 Introduction 56

4.1.1 Defi nition of precompetitive Research 56

4.1.2 Drivers for Change 56

4.2 Examples of Precompetitive Consortia 58

4.2.1 Innovative Medicines Initiative 59

4.2.1.1

Governance 60

4.2.1.2 How IMI Research Process Works 61

4.2.1.3 IP Policy 64

4.2.1.4 Learnings from the IMI 64

4.2.2 Structural Genomics Consortium 66

4.2.2.1

IP Policy 67

4.2.2.2 Governance 67

4.2.2.3 Lessons from the SGC 68

4.3 Implementation and Management of Precompetitive Consortia 68

4.3.1 Best Practice Principles 69

4.3.2 Capturing Value Added in a Collaboration 71

4.3.3 Potential Obstacles to Precompetitive Collaboration 72

4.4 Future Trends 73

Appendix: Summary of Precompetitive Consortia 74
References 83